Skip to content

CONMED CNMD Debt-to-equity

Debt-to-equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.7×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×
Vericel logo
VericelVCEL
0.3×-0.1×
OSI Systems logo
OSI SystemsOSIS
1.2×+0.6×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.6×0.0×
Medtronic logo
MedtronicMDT
0.6×0.0×

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-35.6%
Enterprise value$1.89B-24.5%
P/E19.4×+5.5×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

Based on the most recent quarter.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's debt-to-equity?
CONMED (CNMD) reported debt-to-equity of 0.8× in Q1 2026.
How has CONMED's debt-to-equity changed year-over-year?
CONMED's debt-to-equity decreased by 7.4% year-over-year, from 0.9× to 0.8×.
What is the long-term trend for CONMED's debt-to-equity?
Over 5 years (2020 to 2025), CONMED's debt-to-equity has grown at a -5.1% compound annual growth rate (CAGR), from 1.1× to 0.9×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.